BDBM238877 US10052306, 316::rac-4-(2-((3aR,5s,6aS)- 5-benzyl-5-fluoro- hexahydrocyclopen- ta[c]pyrrol-2(1H)-yl)-1- hydroxyethyl)-2- fluorophenol

SMILES OC(CN1C[C@H]2C[C@@](F)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)c(F)c1

InChI Key InChIKey=OJUPKVPVSGIIKZ-INMRTUIXSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 238877   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM238877(US10052306, 316 | rac-4-(2-((3aR,5s,6aS)- 5-benzyl...)
Affinity DataIC50:  36.4nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent